GAMMA Investing’s Advantest Corp ATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
5,684
+258
+5% +$53.7K 0.04% 351
2026
Q1
$737K Buy
5,426
+362
+7% +$49.2K 0.03% 435
2025
Q4
$640K Buy
5,064
+368
+8% +$46.5K 0.03% 442
2025
Q3
$472K Buy
4,696
+414
+10% +$41.6K 0.03% 530
2025
Q2
$317K Sell
4,282
-1,026
-19% -$75.9K 0.02% 652
2025
Q1
$234K Buy
5,308
+292
+6% +$12.9K 0.02% 696
2024
Q4
$285K Buy
5,016
+1,212
+32% +$69K 0.02% 557
2024
Q3
$180K Buy
3,804
+1,270
+50% +$60.1K 0.02% 669
2024
Q2
$103K Sell
2,534
-737
-23% -$30K 0.01% 761
2024
Q1
$146K Buy
3,271
+639
+24% +$28.5K 0.03% 493
2023
Q4
$105K Buy
+2,632
New +$105K 0.03% 530

Other funds holding ATE

GAMMA Investing's ATE Position: Q2 2026 in Review

GAMMA Investing increased its Advantest Corp (ATE) stake by 4.8% in Q2 2026, buying an estimated $53.7K and bringing the position to 5,684 shares worth $1.18M. The position accounts for 0.04% of the portfolio, ranked #351.

GAMMA Investing first reported a position in ATE in Q4 2023 and has held it in 11 quarters since. 11 funds tracked by Wall St. Rank hold ATE as of Q2 2026.

  • GAMMA Investing held 5,684 shares of Advantest Corp worth $1.18M as of Q2 2026.
  • GAMMA Investing bought 258 Advantest Corp shares in Q2 2026, an estimated $53.7K.
  • Advantest Corp made up 0.04% of GAMMA Investing's portfolio in Q2 2026, its #351 holding.
  • GAMMA Investing first reported a position in Advantest Corp in Q4 2023 and has held it in 11 quarters since.
  • 11 funds tracked by Wall St. Rank held Advantest Corp as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.